SCHEMBL337443

SCHEMBL337443

CC(C)C(CO)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337442 1.00
SCHEMBL2009746 0.79
SCHEMBL13417414 0.77 TSHR (0.35)
Ethane SCHEMBL10659912 0.77 TDP1 (0.40)
SCHEMBL3583584 0.77 SPHK2 (0.37)
SCHEMBL24111165 0.77 TSHR (0.35)
SCHEMBL3583586 0.77 SPHK2 (0.37)
SCHEMBL13417353 0.77 TSHR (0.35)
SCHEMBL13417354 0.75 TSHR (0.33)
SCHEMBL15750870 0.73 LMNA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124490-A1 HIGH STABILITY POLYIONIC LIQUID SALTS Sigma-Aldrich Co. LLC (US) 2017-02-01 EP disclosed
EP-2114969-B1 HIGH STABILITY POLYIONIC LIQUID SALTS SIGMA ALDRICH CO LLC (US) 2016-06-29 EP disclosed
US-8481722-B2 High stability polyionic liquid salts SIGMA-ALDRICH CO. LLC (US) 2013-07-09 US disclosed
US-20120083603-A1 HIGH STABILITY POLYIONIC LIQUID SALTS SIGMA-ALDRICH CO. LLC (US) 2012-04-05 US disclosed
US-8097721-B2 polycationic or polyanionic molecules; use as stationary phases in gas chromatography, and as a reagent in electrospray ionization-mass spectrometry (ESI-MS); thermal stability; tris(anion) such as tris(sulfonate) or tris(cation) groups such as imidazolium, pyrrolidinium, ammonium SIGMA-ALDRICH CO. LLC (US) 2012-01-17 US disclosed
US-20080210858-A1 High Stability Polyionic Liquid Salts SIGMA-ALDRICH CO. NEWCO INC. 2008-09-04 US disclosed
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US disclosed
US-6900313-B2 Chiral ionic liquids MERCK PATENT GMBH (DE) 2005-05-31 US disclosed
EP-1250299-B1 CHIRAL IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2005-04-06 EP disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
US-20030149264-A1 Chiral ionic liquids SOLVENT INNOVATION GMBH (DE) 2003-08-07 US disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed
EP-1250299-A2 CHIRAL IONIC LIQUIDS Solvent Innovation GmbH (DE) 2002-10-23 EP disclosed
WO-2001055060-A2 CHIRAL IONIC LIQUIDS SOLVENT INNOVATION GMBH (DE) 2001-08-02 WO disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
EP-0521827-B1 Pharmacological active hydrazin derivatives and process for their preparation CIBA GEIGY AG (CH) 1996-09-25 EP disclosed
EP-0521827-A1 Pharmacological active hydrazin derivatives and process for their preparation CIBA-GEIGY AG (CH) 1993-01-07 EP disclosed